In vivo-assembled polyhydroxyalkanoate (PHA) particles have been successfully bioengineered to display foreign protein functions toward high-value applications in medicine and industry. To further expand the design space of PHA particles toward immobilization of various functional proteins, we developed a tunable modular protein immobilization method implementing the SpyCatcher/SpyTag chemistry. We successfully displayed the SpyCatcher protein using translational fusion with the Ralstonia eutropha PHA synthase (PhaC). The SpyCatcher domain displayed on the surface of PHA particles was accessible for cross-linker-free ligation with SpyTag-bearing proteins. We demonstrated tunable protein immobilization of various SpyTagged proteins on SpyCatcher-PHA particles, which ultimately enabled assembly of multiple proteins coating the surface of PHA particles. Overall, the functionality, stability, and reusability of proteins immobilized to SpyCatcher-PHA particles were either retained or enhanced in comparison to the soluble forms. This modular platform can be implemented as a generic tool for protein immobilization in an array of applications.

Enzymes function as biocatalysts and are extensively exploited in industrial applications. Immobilization of enzymes using support materials has been shown to improve enzyme properties, including stability and functionality in extreme conditions and recyclability in biocatalytic processing. This review focuses on the recent advances utilizing the design space of in vivo self-assembled polyhydroxyalkanoate (PHA) particles as biocatalyst immobilization scaffolds. Self-assembly of biologically active enzyme-coated PHA particles is a one-step in vivo production process, which avoids the costly and laborious in vitro chemical cross-linking of purified enzymes to separately produced support materials. The homogeneous orientation of enzymes densely coating PHA particles enhances the accessibility of catalytic sites, improving enzyme function. The PHA particle technology has been developed into a remarkable scaffolding platform for the design of cost-effective designer biocatalysts amenable toward robust industrial bioprocessing. In this review, the PHA particle technology will be compared to other biological supramolecular assembly-based technologies suitable for in vivo enzyme immobilization. Recent progress in the fabrication of biological particulate scaffolds using enzymes of industrial interest will be summarized. Additionally, we outline innovative approaches to overcome limitations of in vivo assembled PHA particles to enable finetuned immobilization of multiple enzymes to enhance performance in multi-step cascade reactions, such as those used in continuous flow bioprocessing.